BRASSINOSTEROIDS (BRs)
BRASSINOLIDE(BL) [(22R,23R,24S)-2α,3α,22,23-tetrahydroxy-24-methyl-B-homo-7-oxa-5α-cholestan-6-one]
| MW 480.69,
crystalline; purity >95% (HPLC) |
|
CAS: 72962-43-7; C28H48O6 |
|
| 015
5891 |
1 |
mg |
| 015
5892 |
2
|
mg |
| 015
5893 |
5
|
mg |
BRASSINONE(NBk) [28-norcastasterone, (22R,23R)-2α,3α,22,23-tetrahydroxy-5α-cholestan-6-one]
| MW 450.66,
crystalline; purity >98% (HPLC) |
|
CAS: 83464-85-1; C27H46O5 |
|
| 015
5631 |
1 |
mg |
| 015
5632 |
2
|
mg |
| 015
5633 |
5
|
mg |
CAMPESTANOL (CAMP) [ (24R)-3-β-hydroxy-24-methyl-5α-cholestane]
| MW 402.71; crystalline; purity > 90% ( HPLC ) |
|
CAS: 474-60-2; C28H50O |
|
| 015 6781 |
100 |
µg |
| 015 6782 |
200 |
µg |
| 015 6783 |
500 |
µg |
6-OXOCAMPESTANOL (OCAMP) [ (24R)-3-β-hydroxy-24-methyl-5α-cholestane-6-one]
| MW 416.69; crystalline; purity > 90% ( HPLC ) |
|
CAS: 168113-32-4; C28H48O2 |
|
| 015 6791 |
100 |
µg |
| 015 6792 |
200 |
µg |
| 015 6793 |
500 |
µg |
CAMPESTEROL (CR) [3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14, 15,16,17-dodecahydro-1H-cyclopentaphenanthren-3-ol]
| MW 400.69; crystalline; purity > 98% ( HPLC ) |
|
CAS: NONE; C28H48O |
|
| 015 6921 |
100 |
µg |
| 015 6922 |
200 |
µg |
| 015 6923 |
500 |
µg |
CASTASTERONE (Bk) [ (22R,23R,24S)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestan-6-one]
| MW 464.69; crystalline; purity > 95% ( HPLC ) |
|
CAS: 80736-41-0; C28H48O5
|
|
| 015 6651 |
1 |
mg |
| 015 6652 |
2 |
mg |
| 015 6653 |
5 |
mg |
CATHASTERONE (CATH) [ (22S,24R)-3-β,22-dihydroxy-24-methyl-5α-cholestane-6-one]
| MW 432.69; crystalline; purity > 95% ( HPLC ) |
|
CAS: 168146-23-4; C28H48O3 |
|
| 015 6761 |
100 |
µg |
| 015 6762 |
200 |
µg |
| 015 6763 |
500 |
µg |
6-DEOXOCATHASTERONE (DECATH) [ (22S,24R)-3-β,22-dihydroxy-24-methyl-5α-cholestane]
| MW 418.71; crystalline; purity > 90% ( HPLC ) |
|
CAS: 198416-73-8; C28H50O2 |
|
| 015 6771 |
100 |
µg |
| 015 6772 |
200 |
µg |
| 015 6773 |
500 |
µg |
EPISECASTEROL [(22R,23R,24S)-5α,22,23-dihydroxy- ergost-2-en-6-one]
| MW 430.68; crystalline; purity > 95% ( HPLC ) |
|
CAS: NONE; C28H46O3
|
|
| 015 6671 |
100 |
µg |
| 015 6672 |
200 |
µg |
| 015 6673 |
500 |
µg |
ERGOSTEROL (ERG) [5,7,22-Ergostatrien-3β-ol, provitamin D2]
| MW 396.66,
crystalline; purity >95% (HPLC) |
|
CAS: 57-87-4; C28H44O |
|
| 015
5731 |
5 |
g |
| 015
5732 |
25 |
g |
| 015
5733 |
100
|
g |
EPIBRASSINOLIDE (EBI) [24-epibrassinolide,
(22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-B-homo-7-oxa-5α-cholestane-6-one]
| MW
480.69,crystalline; purity >98%
(HPLC) |
|
CAS: 78821-43-9; C28H48O6 |
|
| 015
0201 |
5 |
mg |
| 015
0202 |
10
|
mg |
| 015
0203 |
50
|
mg |
TRIS-EPIBRASSINOLIDE(TEBI) [(22S,23S,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-B-homo-7-oxa-5α-cholestane-6-one]
| MW 480.69,
crystalline; purity >98% (HPLC) |
|
CAS: 78821-42-8; C28H48O6 |
|
| 015
5681 |
1 |
mg |
| 015
5682 |
2
|
mg |
| 015
5683 |
5
|
mg |
EPICASTASTERONE (EBk) [24-epicastasterone,
(22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestane-6-one]
| MW 464.69,, crystalline:
241-245 oC, purity >98% (HPLC) |
|
CAS: 72050-71-6; C28H48O5 |
|
| 015
0901 |
1 |
mg |
| 015
0902 |
2
|
mg |
| 015
0903 |
5 |
mg |
6-DEOXOCASTASTERONE (6deoxoCS) [(22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestane]
| MW 450.71; crystalline; purity > 98% ( HPLC ) |
|
CAS: 87833-54-3; C28H50O4 |
|
| 015 7511 |
100 |
µg |
| 015 7512 |
200 |
µg |
| 015 7513 |
500 |
µg |
TRIS-EPICASTASTERONE(TEBk) [(22S,23S,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestane-6-one]
| MW 464.69,
crystalline; purity >98% (HPLC) |
|
CAS: 72050-69-2; C28H48O5 |
|
| 015
5691 |
1 |
mg |
| 015
5692 |
2
|
mg |
| 015
5693 |
5
|
mg |
23,24-TRIS-EPICASTASTERONE (TECs) [(22,23,24R)-2β,3β,22,23-tetrahydroxy-24-methyl-5α-cholestane-6-one]
| MW 464.69,
crystalline; purity >98% (HPLC) |
|
CAS: 375396-54-6; C28H48O5 |
|
| 015
5821 |
1 |
mg |
| 015 5822 |
2
|
mg |
| 015 5823 |
5
|
mg |
3,24-DIEPICASTASTERONE (EBk3β) [(22R,23R,24R)-2α,3β,22,23-tetrahydroxy-24-methyl-5α-cholestane-6-one]
| MW 464.69, crystalline; purity >98% (HPLC) |
|
CAS: 121468-16-4; C28H4805 |
|
| 015
0911 |
1 |
mg |
| 015
0912 |
2
|
mg |
| 015
0913 |
5
|
mg |
6-DEOXO-24-EPICASTASTERONE (EBd)[(22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestane]
| MW 450.71, crystalline; purity >98% (HPLC) |
|
CAS: 169869-41-4; C28H50O4 |
|
| 015
0921 |
1 |
mg |
| 015
0922 |
2
|
mg |
| 015
0923 |
5
|
mg |
HOMOCASTASTERONE [(22R,23R,24S)-2α,3α,22,23-tetrahydroxy--24ethyl-5α-cholestan-6-one]
| MW 478.72, crystalline; purity >95%
(HPLC) |
|
CAS: 83509-42-6; C29H50O5 |
|
| 015
6011 |
1 |
mg |
| 015
6012 |
2
|
mg |
| 015
6013 |
5
|
mg |
HOMOBRASSINOLIDE (HBI) [(22R,23R,24S)-2α,3α,22,23-tetrahydroxy-24-ethyl-B-homo-7-oxa-5α-cholestan-6-one]
|
MW 494.72, crystalline; purity >95% (HPLC) |
|
CAS: 74174-44-0; C29H50O6 |
|
| 015
6021 |
1 |
mg |
| 015
6022 |
2
|
mg |
| 015
6023 |
5
|
mg |
NORBRASSINOLIDE (NBI) [28-norbrassinolide, (22R,23R)-2α,3α,22,23-tetrahydroxy-B-homo-7-oxa-5α-cholestan-6-one]
| MW 466.66,
crystalline; purity >98% (HPLC) |
|
CAS: 77736-43-7; C27H46O6 |
|
| 015
5621 |
1 |
mg |
| 015
5622 |
2
|
mg |
| 015
5623 |
5
|
mg |
6-DEOXO-28-NORCASTASTERONE(NBd) [(22R,23R)-2α,3α,22,23-tetrahydroxy-5α-cholestane]
| MW 436.68,
crystalline; purity >98% (HPLC) |
|
CAS: 169624-26-4; C27H48O4 |
|
| 015
5641 |
100 |
µg |
| 015
5642 |
200
|
µg |
| 015
5643 |
500
|
µg |
NORTEASTERONE (NTEA)[ (22R,23R)-3β-5α,3,22,23-trihydroxy- cholestan-6-one]
| MW 434.67; crystalline; purity > 95% ( HPLC ) |
|
CAS: 105319-58-2; C27H46O4
|
|
| 015 6661 |
100 |
µg |
| 015 6662 |
200 |
µg |
| 015 6663 |
500 |
µg |
SS-HOMOCASTASTERONE [(22S,23S)-2α,3α,22,23-tetrahydroxy--24ethyl-5α-cholestan-6-one]
|
MW 478.72, crystalline; purity >95% (HPLC) |
|
CAS: 80483-89-2; C29H50O5 |
|
| 015
6051 |
1 |
mg |
| 015
6052 |
2
|
mg |
| 015
6053 |
5
|
mg |
SS-HOMOBRASSINOLIDE [(22S,23S)-2α,3α,22,23-tetrahydroxy-24-ethyl-5α-cholestan-6-one]
|
MW 494.72, crystalline; purity >95% (HPLC) |
|
CAS: 74174-44-0; C29H50O6 |
|
| 015
6061 |
1 |
mg |
| 015
6062 |
2
|
mg |
| 015
6063 |
5
|
mg |
TYPHASTEROL (TY)[(3α-5α,22R,23R,24S)-3,22,23-trihydroxy-Ergostan-6-one]
| MW 448.69; crystalline; purity > 90% ( HPLC ) |
|
CAS: 87734-68-7; C27H46O4
|
|
| 015 7161 |
100 |
µg |
| 015 7162 |
200 |
µg |
| 015 7163 |
500 |
µg |
6-DEOXYTYPHASTEROL (6deoxoTY)[(3α-5α,22R,23R,24S)-Ergostane-3,22,23-triol]
| MW 434.71; crystalline; purity > 90% ( HPLC ) |
|
CAS: 164034-47-3; C28H50O3
|
|
| 015 7541 |
100 |
µg |
| 015 7542 |
200 |
µg |
| 015 7543 |
500 |
µg |